Dicumarol

CHEMBL1466 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

336.3 g/mol

LogP

2.6

Phase

4

An anticoagulant that inhibits vitamin K-dependent clotting factors, originally derived from spoiled sweet clover hay. It is used to prevent blood clots but has largely been replaced by other anticoagulants.

Moleküler Ağırlık

336,3000 g/mol

LogP

2,60

TPSA

93,10 Å²

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O

InChI

InChI=1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,20-21H,9H2

Molecular Formula

C19H12O6

HBD / HBA

2 / 6

Döndürülebilir Bağlar

2

Ağır Atomlar

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An anticoagulant that inhibits vitamin K-dependent clotting factors, originally derived from spoiled sweet clover hay. It is used to prevent blood clots but has largely been replaced by other anticoagulants.

Yes, Dicumarol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1466. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 54676038. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-08-20.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Dicumarol PillFYI'da

Yapı

Hızlı Veriler

Formül: C19H12O6

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.